Should the term ‘antipsychotic’ be changed to ‘multidimensional stabiliser’ in bipolar disorder? Towards a new denomination for ‘atypical antipsychotics’-Reference-Cited by-同舟云学术

Should the term ‘antipsychotic’ be changed to ‘multidimensional stabiliser’ in bipolar disorder? Towards a new denomination for ‘atypical antipsychotics’

Published:2013-05-31 Issue:8 Volume:47 Page:707-709
ISSN:0004-8674
Container-title:Australian & New Zealand Journal of Psychiatry
language:en
Short-container-title:Aust N Z J Psychiatry

Author:

Altamura Alfredo Carlo¹,Dragogna Filippo¹

Affiliation:

1. Department of Psychiatry, Mood Disorder Treatment Unit, University of Milan, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy

Publisher

SAGE Publications

Subject

Psychiatry and Mental health,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/0004867413492572

Reference24 articles.

1. Flupenthixol decanoate in recurrent manic-depressive illness.

2. Novel antipsychotics and the problem of clinical stabilization in schizophrenia

3. From ‘classical’ antipsychotics to ‘multidimensional stabilizers’: do we need a new classification for novel drugs used in schizophrenia?

4. Mood stabilizers for patients with bipolar disorder: the state of the art

5. Effect of Quetiapine and Norquetiapine on Anxiety and Depression in Major Psychoses Using a Pharmacokinetic Approach

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sociodemographic and clinical factors associated with prescription of first- versus second-generation long-acting antipsychotics in incarcerated adult males;International Clinical Psychopharmacology;2023-10-02

2. Which factors delay treatment in bipolar disorder? A nationwide study focussed on duration of untreated illness;Early Intervention in Psychiatry;2020-10-15

3. Psychotic versus non-psychotic bipolar disorder: Socio-demographic and clinical profiles in an Italian nationwide study;Australian & New Zealand Journal of Psychiatry;2019-01-18

4. Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review;Therapeutics and Clinical Risk Management;2017-06

5. Haloperidol versus second-generation antipsychotics in the long-term treatment of schizophrenia;Human Psychopharmacology: Clinical and Experimental;2016-06-13